EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characteristics and Resistance Patterns of Gram-Negative Bacterial Isolates to Third-Generation Cephalosporins in Oncology ICU Patients: A Ten-Year Retrospective Analysis

Omar Khresat iD, Sawsan Mubarak, Joud Jarrah, Hadeel AlGhawrie iD

Pathogens · 2026

DOI: 10.3390/pathogens15101083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2026. Verfasst von Omar Khresat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Infection Control Program, King Hussein Cancer Center, Amman 11941, Jordan. Hauptthemen laut MEDLINE: Third Generation Cephalosporins, Gram-Negative Bacteria, Gram-Negative Bacterial Infections, Anti-Bacterial Agents. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Third-generation cephalosporin (3GC) resistance threatens empirical therapy in vulnerable critically ill patients. We conducted a decade-long single-center retrospective study of 3528 Gram-negative isolates from 1946 adult and pediatric oncology intensive care unit (ICU) patients between 2015 and 2024 at King Hussein Cancer Center. This study aims to characterize 3GS resistance in oncology ICU patients. The 3GC resistance was 59.2% among Enterobacterales and other fermenting organisms (evaluated against the full three-agent panel) and 67.2%among non-fermenters (Pseudomonas aeruginosa, Acinetobacter spp., Stenotrophomonas maltophilia; evaluated against a narrower, organism-appropriate agent subset); these two estimates are not directly comparable given the differing susceptibility panels tested. Resistance was highest among the Acinetobacter calcoaceticus-baumannii complex (96.9%), followed by Escherichia coli (70.5%), Enterobacter cloacae (65.5%), and Klebsiella pneumoniae (59.6%). In unadjusted patient-level analyses, resistance was significantly higher among patients with hematological malignancy than solid tumors (73.1% vs. 57.8%; OR 1.98, 95% CI 1.59–2.48; p < 0.001) and among pediatric versus adult ICU isolates (70.8% vs. 60.9%; OR 1.55, 95% CI 1.11–2.18; p = 0.010). Seven-day mortality did not differ by resistance status (44.1% vs. 41.6%; unadjusted OR 1.11, 95% CI 0.92–1.33). The 3GC resistance varies by organism, malignancy type and ICU population in unadjusted analyses, supporting population-specific antibiograms and stronger stewardship.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Third Generation CephalosporinsGram-Negative BacteriaGram-Negative Bacterial InfectionsAnti-Bacterial AgentsDrug Resistance, BacterialNeoplasmsCephalosporinsHumansRetrospective StudiesIntensive Care UnitsFemaleMicrobial Sensitivity TestsMaleMiddle AgedAdultAgedChild

Stichwörter der Autor:innen

antimicrobial resistancegram-negative bacteriahematological malignancyintensive care unitoncologythird-generation cephalosporins

Substanzen

Third Generation CephalosporinsAnti-Bacterial AgentsCephalosporins

Autor:innen und Institutionen

  • Infection Control Program, King Hussein Cancer Center, Amman 11941, Jordan.
  • Department of Medicine, King Hussein Cancer Center, Amman 11941, Jordan.

ORCID-Profile: Omar Khresat, Hadeel AlGhawrie

Zitieren

APA

Khresat, O., Mubarak, S., Jarrah, J., & AlGhawrie, H. (2026). Characteristics and Resistance Patterns of Gram-Negative Bacterial Isolates to Third-Generation Cephalosporins in Oncology ICU Patients: A Ten-Year Retrospective Analysis. Pathogens. https://doi.org/10.3390/pathogens15101083

Vancouver

Khresat O, Mubarak S, Jarrah J, AlGhawrie H. Characteristics and Resistance Patterns of Gram-Negative Bacterial Isolates to Third-Generation Cephalosporins in Oncology ICU Patients: A Ten-Year Retrospective Analysis. Pathogens. 2026. doi:10.3390/pathogens15101083

BibTeX
@article{Khresat2026,
  author = {Khresat, Omar and Mubarak, Sawsan and Jarrah, Joud and AlGhawrie, Hadeel},
  title = {Characteristics and Resistance Patterns of Gram-Negative Bacterial Isolates to Third-Generation Cephalosporins in Oncology ICU Patients: A Ten-Year Retrospective Analysis},
  journal = {Pathogens},
  year = {2026},
  doi = {10.3390/pathogens15101083}
}
Kostenlos starten →